Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 104

1.

Infections: a double-edge sword in autoimmunity.

Shamriz O, Shoenfeld Y.

Curr Opin Rheumatol. 2018 Jul;30(4):365-372. doi: 10.1097/BOR.0000000000000490.

PMID:
29847440
2.

Vaccines to Children: Protective Effect and Adverse Events: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2009 Feb.

3.

Prevention, Detection, and Management of Diabetes in South Dakota.

Hogue AL, Huntington MK.

S D Med. 2017 Spec;Spec No:47-53.

PMID:
28817863
4.

Hepatitis B vaccine non response: A predictor of latent autoimmunity?

Mormile R.

Med Hypotheses. 2017 Jul;104:45-47. doi: 10.1016/j.mehy.2017.05.020. Epub 2017 May 25.

PMID:
28673589
5.

Chronic hepatitis B virus infection status is more prevalent in patients with type 2 diabetes.

Lu J, Hou X, Tu H, Tang Z, Xiang Y, Bao Y, Gu J, Jia W.

J Diabetes Investig. 2017 Jul;8(4):619-625. doi: 10.1111/jdi.12609. Epub 2017 Mar 13.

6.

Seroprotection status of hepatitis B and measles vaccines in children with type 1 diabetes mellitus.

Onal Z, Ersen A, Bayramoglu E, Yaroglu Kazancı S, Onal H, Adal E.

J Pediatr Endocrinol Metab. 2016 Sep 1;29(9):1013-7. doi: 10.1515/jpem-2015-0211.

PMID:
27658137
7.

The correlation analysis of primary liver cancer with Type 2 diabetes.

Su Q, Sun F, Li J, Zhang H, Wang M, Zhou H, Qiao L.

Indian J Cancer. 2015 Dec;52 Suppl 3:E148-52. doi: 10.4103/0019-509X.186557.

8.

SEROLOGICAL RESPONSE TO VACCINES IN CHILDREN WITH DIABETES.

Dashti AS, Alaei MR, Musavi Z, Faramarzi R, Mansouri F, Nasimfar A.

Roum Arch Microbiol Immunol. 2015 Jul-Dec;74(3-4):112-7.

PMID:
27328526
9.

Diabetes prevention through prevention of hepatitis B.

Lin J, Ou HY, Chuang LM, Chiu KC.

Hepatology. 2016 Sep;64(3):987-8. doi: 10.1002/hep.28399. Epub 2016 Feb 19. No abstract available.

PMID:
26660511
10.

Vaccinations and childhood type 1 diabetes mellitus: a meta-analysis of observational studies.

Morgan E, Halliday SR, Campbell GR, Cardwell CR, Patterson CC.

Diabetologia. 2016 Feb;59(2):237-43. doi: 10.1007/s00125-015-3800-8. Epub 2015 Nov 12. Review.

11.

Diabetes and Hepatitis C: A Two-Way Association.

Hammerstad SS, Grock SF, Lee HJ, Hasham A, Sundaram N, Tomer Y.

Front Endocrinol (Lausanne). 2015 Sep 14;6:134. doi: 10.3389/fendo.2015.00134. eCollection 2015. Review.

12.

Hepatitis B virus vaccination failure in celiac disease and type 1 diabetes: what is the truth?

Mormile R.

Int J Colorectal Dis. 2016 May;31(5):1049. doi: 10.1007/s00384-015-2383-7. Epub 2015 Sep 7. No abstract available.

PMID:
26346929
13.

Covariation of the incidence of type 1 diabetes with country characteristics available in public databases.

Diaz-Valencia PA, Bougnères P, Valleron AJ.

PLoS One. 2015 Feb 23;10(2):e0118298. doi: 10.1371/journal.pone.0118298. eCollection 2015.

14.

Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.

Lee BS, Park EC, Park SW, Nam CM, Roh J.

World J Gastroenterol. 2015 Jan 14;21(2):502-10. doi: 10.3748/wjg.v21.i2.502.

15.

Normal or defective immune response to Hepatitis B vaccine in patients with diabetes and celiac disease.

Zanoni G, Contreas G, Valletta E, Gabrielli O, Mengoli C, Veneri D.

Hum Vaccin Immunother. 2015;11(1):58-62. doi: 10.4161/hv.34309. Epub 2014 Nov 1.

16.

Assessment of evidence for positive association and seroprevalence of hepatitis B and C in diabetic patients in a developing country.

Korkmaz H, Kesli R, Onder Pamuk B, Ipekci SH, Terzi Y, Kebapcilar L.

J Investig Med. 2015 Feb;63(2):251-7. doi: 10.1097/JIM.0000000000000126.

PMID:
25415060
17.

[Breastfeeding: health benefits for child and mother].

Comité de nutrition de la Société française de pédiatrie, Turck D, Vidailhet M, Bocquet A, Bresson JL, Briend A, Chouraqui JP, Darmaun D, Dupont C, Frelut ML, Girardet JP, Goulet O, Hankard R, Rieu D, Simeoni U.

Arch Pediatr. 2013 Nov;20 Suppl 2:S29-48. doi: 10.1016/S0929-693X(13)72251-6. French.

PMID:
25063312
18.

Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon.

Boglione L, Cusato J, De Nicolò A, Cariti G, Di Perri G, D'Avolio A.

J Viral Hepat. 2015 Mar;22(3):318-27. doi: 10.1111/jvh.12288. Epub 2014 Jul 24.

19.

Prevalence of hepatitis B virus in patients with diabetes mellitus: a comparative cross sectional study at Woldiya General Hospital, Ethiopia.

Mekonnen D, Gebre-Selassie S, Fantaw S, Hunegnaw A, Mihret A.

Pan Afr Med J. 2014 Jan 21;17:40. doi: 10.11604/pamj.2014.17.40.2465. eCollection 2014.

20.

Vaccination practices for hepatitis B, influenza, and pneumococcal disease for people with diabetes.

American Association of Diabetes Educators.

Diabetes Educ. 2014 Jan-Feb;40(1):122-4. doi: 10.1177/0145721713513545. No abstract available.

PMID:
24442103

Supplemental Content

Loading ...
Support Center